Skip to main content
Novartis
language-selector-globe
Choose Location
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English(link is external)
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English(link is external)
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • About 

      Team meeting
      About

      Every day, we work to reimagine medicine to improve and extend people’s lives. Learn about us and our story.

      • Novartis in the US 
      • People and culture 
      • Products 
      • Therapeutic areas 
      • Inclusion and belonging 
      • Manufacturing 
      • Contact us 
    • Patients and caregivers 

      • Novartis commitment to patients and caregivers 
      • Patient assistance 
      • Diseases 

        • Chronic spontaneous urticaria (CSU) 
        • Hidradenitis suppurativa (HS) 
        • Prostate Cancer (PC) 
        • Paroxysmal Nocturnal Hemoglobinuria (PNH) 
        • Breast Cancer 
        • Sjögren's Disease 
      • Participating in clinical trials 
      • Adverse event reporting 
      • Patient resources 
      Patient smiling at doctor image
      Patients and caregivers

      Visit resources tailored for our patient communities and their caregivers, including information around patient assistance, disease information and related resources.

    • Healthcare professionals 

      • Novartis pipeline 
      • Novartis clinical trials 
      • Adverse event reporting 
      • External funding 
      • HCP resources 
      • Personalized and Precision Medicine 
      • Health Information Technology Resources 
      Two doctors examining X-ray
      Healthcare professionals

      Visit our resource hub for information around clinical trials, our products and innovation pipeline.

    • ESG 

      • Ethical behavior 

        • Code of ethics 
        • SpeakUp 
        • PhRMA Code on interactions with healthcare professionals 
        • Business principles 
      • Ethics, risk and compliance 

        • Pay transparency-EPIC 
        • Compliance program 
        • State laws 
        • Corporate integrity agreement 
        • Payments to HCPs & HCOs 
        • Drug Supply Chain Security Act Information 
      • Corporate responsibility 

        • Novartis in Society Integrated Report 
        • Novartis US Foundation 
        • People and communities 
        • Beacon of hope 

      • Environmental sustainability 
      Family and friends party at home
      ESG

      Learn about our commitment to making a positive impact on society through innovative medicine access, sustainability, and governance.

    • News 

      • News archive 
      • Statements 
      • Stories 
      • Contacts 
      Co-workers having a meeting
      News

      Check out our media hub for the latest news, stories, and updates from across our business.

    • Careers 

      • Career search 
      • Early career 
      • Employee benefits 
      • Inclusion and belonging  
      Colleagues laughing
      Careers

      Check out what careers are available at Novartis in the U.S. and learn about our people and culture.

    Grandmother, mother and daughter smiling and laughing on a beach
    Home

    Working together, we can reimagine medicine to improve and extend people’s lives.

  1. Home
  2. Careers
  3. Career Search
  • Sort by Sort ascending
  • Job Title Sort ascending
  • Site
  • Location
  • Division
  • Business
  • Functional Area
  • Date Posted
Job Title Sort ascending Site Location Division Business Functional Area Date Posted
Digital Finance-Manager Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 19, 2025
Digital Finance, Manager (Analytics Operations) Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 19, 2025
Global Finance Master Data Specialist Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance May 19, 2025
FRA Analyst Treasury and Cash Management (m/f/d) / Analitik - specialist (m/ž/d) Ljubljana Slovenia Finance Universal Hierarchy Node Audit & Finance May 19, 2025
Global Financial Controls and Compliance (FCC) Process Expert – Source to Pay (S2P), T&E (Travel and Expenses) and PRO (Procurement) Home Worker United Kingdom Finance CTS Audit & Finance May 19, 2025
BPA Manager Telangana India Finance Universal Hierarchy Node Audit & Finance May 18, 2025
TCM Payment Specialist Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance May 15, 2025
Manager - Corporate BPA Basel (City) Switzerland Finance Corporate Audit & Finance May 15, 2025
Business Planning & Analysis Manager Bogota (Pharmaceuticals / GDD / NTO / CTS) Colombia Finance Innovative Medicines Audit & Finance May 15, 2025
Specialist R2R Intercompany Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 14, 2025
Senior EBA Specialist Prague Czech Republic Finance CTS Audit & Finance May 14, 2025
Manager - IMI BPA Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 14, 2025
R2R Lead - 18 meses Sintra Portugal Finance CTS Audit & Finance May 13, 2025
Senior Financial Analyst Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance May 12, 2025
Record to Report Sr Specialist US INSURGENTES Mexico Finance CTS Audit & Finance May 07, 2025
Senior Specialist - Management Reporting INSURGENTES Mexico Finance CTS Audit & Finance May 07, 2025
Vodja računovodstva (m/ž/d) / Record to Report (R2R) Lead (m/f/d) Ljubljana Slovenia Finance Universal Hierarchy Node Audit & Finance May 06, 2025
Tax Manager Makati City Philippines Finance Universal Hierarchy Node Audit & Finance May 01, 2025
R2R Senior Specialist - Inventory Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Apr 21, 2025
Executive Director, Government Healthcare Administration East Hanover USA Finance Innovative Medicines Audit & Finance Apr 21, 2025
R2R GL Team Lead Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Apr 17, 2025
R2R Associate Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Apr 16, 2025
Associate Director, General Management & Strategy Business Planning & Analysis (2 Positions) East Hanover USA Finance Innovative Medicines Audit & Finance Apr 15, 2025
Comptable Général(e) Expérimenté(e) H/F Paris Headquarter (Novartis Pharma S.A.S.) France Finance CTS Audit & Finance Apr 15, 2025
Senior Tax Specialist (m/w/d) Schaftenau Austria Finance CTS Audit & Finance Apr 10, 2025
P2P & T&E Ops Specialist (French Speaker) Selangor Malaysia Finance CTS Audit & Finance Apr 10, 2025
Director, BD&L Finance East Hanover USA Strategy & Growth Corporate Audit & Finance Mar 31, 2025
FRA Head Baltics Latvia Latvia Finance Innovative Medicines Audit & Finance Mar 19, 2025
FC&C Manager Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Mar 19, 2025
Senior Manager, BPA Operations Toranomon (NPKK Head Office) Japan Finance Universal Hierarchy Node Audit & Finance Mar 19, 2025
Davčni manager (m/ž/d) / Tax Manager (m/f/d) Ljubljana Slovenia Finance Corporate Audit & Finance Mar 18, 2025
Analitik v oddelku Računovodstvo kupcev (m/ž) / FRA Analyst in Order to Cash department (m/f) Ljubljana Slovenia Finance Universal Hierarchy Node Audit & Finance Feb 20, 2025
R2R Specialist - GL & Reporting Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Feb 20, 2025
R2R Senior Specialist - Statutory Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Feb 04, 2025
R2R Senior Specialist Bucuresti Romania Finance CTS Audit & Finance Jan 27, 2025
FRA Analyst Kyiv Ukraine Finance CTS Audit & Finance Jan 16, 2025
R2R Specialist - GL & Reporting Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Jan 10, 2025
Assistant Manager SOD Ops Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance Dec 19, 2024
Manager - FC&C Hyderabad (Office) India Finance CTS Audit & Finance Nov 19, 2024
Chief Financial Officer - Manufacturing - Targu Mures Targu Mures Romania Operations Universal Hierarchy Node Audit & Finance Nov 18, 2024
Tax Team Lead Warsaw Poland Finance CTS Audit & Finance Nov 11, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Oct 15, 2024
General Accounting Manager INSURGENTES Mexico Finance CTS Audit & Finance Oct 09, 2024
R2R Specialist - GL & Reporting Selangor Malaysia Finance Universal Hierarchy Node Audit & Finance Oct 08, 2024
S2P Business Partner Selangor Malaysia Finance CTS Audit & Finance Sep 24, 2024
Senior Manager ERP Assurance Hyderabad (Office) India Finance CTS Audit & Finance Sep 23, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Universal Hierarchy Node Audit & Finance Sep 17, 2024
Record to Report Specialist INSURGENTES Mexico Finance CTS Audit & Finance Sep 05, 2024
FRA Technical Accounting & Special Projects APMA Selangor Malaysia Operations Universal Hierarchy Node Audit & Finance Aug 22, 2024
Business Planning and Analysis Manager, Novartis Technical Operations INSURGENTES Mexico Finance Innovative Medicines Audit & Finance Aug 22, 2024

Pagination

  • ‹ Previous page
  • 1
  • 2
  • › Next page

Novartis United States

Navigate Novartis
  • Patients & caregivers
  • Healthcare professionals
  • ESG
  • News
  • Careers
Media center
  • News archive
  • Statements
  • Stories
Our portfolio
  • Novartis clinical pipeline
  • Novartis product portfolio
Other Novartis US websites
  • Oncology HCP resources
  • Medical information(link is external)
  • Global site
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
  • (link is external)
Footer Bottom
© 2025 Novartis Pharmaceuticals Corporation
  • Terms of use
  • Privacy policy
  • Consumer health privacy policy
  • Contacts
  • Site map
  • Web accessibility
Novartis Site Directory
This site is intended for US residents only